Downloads

1. BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D. 2/5/2023

   The Business of Biotech podcast took to the streets of San Francisco during the 41st Annual J.P. Morgan Healthcare Conference. This week's episode features a conversation with Sangamo Therapeutics CEO Sandy Macrea, Ph.D., who rationalizes the company's aggressive pipeline development and its decision to invest in multinational AAV and cell therapy manufacturing facilities in France and California. Dr. Macrea zeroes in on the relationship between people and processes that's enabled the company to grow to more than 500 associates working on nearly 20 cell therapy, gene therapy, and genome engineering programs. 

2. 2023 Market Outlook with AdBio and ISCT's Miguel Forte 2/1/2023

   Miguel Forte is Entrepreneur in Residence at AdBio, a VC firm based in France, and President Elect of ISCT. Forte and Cell & Gene: The Podcast host, Erin Harris, break down market outlook perspective for the cell and gene therapy space. He provides valuable tips to employ when seeking VC partnership, and he covers ISCT's primary focus areas and what to expect from ISCT 2023 Paris.

3. After Decades Of Biomanufacturing Workforce Development, What’s Next? 2/1/2023

   We have seen exponential growth of the biotech industry in recent decades. Companies have struggled to find qualified workers. To close that workforce gap, we need to leverage the lessons from successful biomanufacturing training programs and consider new approaches.

4. Secure File Sharing And Collaboration For CROs 1/30/2023

   Explore what is at stake when it comes to CRO-to-sponsor data sharing and collaboration. Additionally, discover a cloud-based solution that ensures trial data is secure, compliant, and properly governed.

5. Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D. 1/29/2023

   Is it past time for a new approach to the COVID vaccine? Ocugen Chairman of the Board, Founder & CEO Shankar Musunuri, Ph.D. says yes, and his ideals would mark significant improvements: fewer shots, better durability, less post-vaccination transmission, and safety proven by time-tested technology. 

6. Process Control And Performance Of A Depth Filtration System 1/24/2023

   Explore a demonstration of strategic process control in terms of flow and pressure, by utilizing a depth filtration system, for effective depth filter processing and recovery of excess product.

7. The Accelerator e-Training Center 1/23/2023

   Discover an e-training center that provides a digital training and continuous learning platform that can be accessed 24/7, by a large number of users, to accommodate biopharmaceutical training demand.

8. Genderless Sterile Connector 1/23/2023

   Learn about a next generation genderless sterile connector for a large range of biopharmaceutical applications. Explore key design features, sterilization specifications, benefits, applications, and more.

9. Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed 1/22/2023

   Cullinan Oncology CEO Nadim Ahmed shares how his company's drug discovery efforts have yielded a wide range of multi-modal oncology candidates. We dig into the company's transition from R&D to the clinic, how it's built an uncommonly comfortable cash position through partnership, and its ambition to become a commercial-stage biotech. 

10. CMC And Scale Up With Mustang Bio's Robert Sexton 1/19/2023

    Mustang Bio's Robert Sexton, VP Program and Alliance Leadership, explains the why behind the need for this role in any CGT company. Having worked for Novartis, Sanofi, Legend Biotech, and more, with responsibilities having included quality, operations, and order management, Sexton is currently responsible for aspects of CMC. As such, he addresses the industry's top CMC challenges as well as sound advice for future scale up.